Cilostazol Stroke Prevention Study for Antiplatelet Combination

Trial Profile

Cilostazol Stroke Prevention Study for Antiplatelet Combination

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin; Clopidogrel
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms CSPS-com
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 03 Dec 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01995370).
    • 12 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top